Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | V. I. Kiselev, V. M. Drukh, E. L. Muyzhnek, I. N. Kuznetsov, O. I. Pchelintseva, M. A. Paltsev |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Experimental Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000294098 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer
by: Kiselev, V.I., et al.
Published: (2014)
by: Kiselev, V.I., et al.
Published: (2014)
Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts
by: Reznikov, A.G., et al.
Published: (2011)
by: Reznikov, A.G., et al.
Published: (2011)
The function of poliamine metabolism in prostate cancer
by: Palavan-Unsal, N., et al.
Published: (2006)
by: Palavan-Unsal, N., et al.
Published: (2006)
Expression of cancer-associated genes in prostate tumors
by: Rosenberg, E.E., et al.
Published: (2017)
by: Rosenberg, E.E., et al.
Published: (2017)
Gene expression of polyamine metabolism proteins in human prostate cancer and benign prostatic hyperplasia
by: V. V. Bentrad, et al.
Published: (2020)
by: V. V. Bentrad, et al.
Published: (2020)
Development of gene expression panels to determine prostate cancer
by: G. V. Gerashchenko, et al.
Published: (2019)
by: G. V. Gerashchenko, et al.
Published: (2019)
Development of gene expression panels to determine prostate cancer
by: Gerashchenko, G.V., et al.
Published: (2019)
by: Gerashchenko, G.V., et al.
Published: (2019)
NANOG as prognostic factor of prostate cancer course
by: Zadvornyi, T.V., et al.
Published: (2023)
by: Zadvornyi, T.V., et al.
Published: (2023)
Morpholoogical features of castratoin-resistent prostate cancer
by: L. H. Rosha, et al.
Published: (2018)
by: L. H. Rosha, et al.
Published: (2018)
Precision therapy to target apoptosis in prostate cancer
by: G. Kulik
Published: (2014)
by: G. Kulik
Published: (2014)
The effect of metabolic syndrome on prostatic cancer development
by: T. A. Nalbandjan
Published: (2016)
by: T. A. Nalbandjan
Published: (2016)
Precision therapy to target apoptosis in prostate cancer
by: Kulik, G.
Published: (2014)
by: Kulik, G.
Published: (2014)
Molecular profiling and genomic microarrays in prostate cancer
by: Golias, Ch., et al.
Published: (2007)
by: Golias, Ch., et al.
Published: (2007)
Rat xenograft chondrosarcoma development by human tissue fragment
by: Hemmati, M., et al.
Published: (2011)
by: Hemmati, M., et al.
Published: (2011)
Survival rates of familial and sporadic prostate cancer patients
by: J. Plonis, et al.
Published: (2015)
by: J. Plonis, et al.
Published: (2015)
Survival rates of familial and sporadic prostate cancer patients
by: Plonis, J., et al.
Published: (2015)
by: Plonis, J., et al.
Published: (2015)
Effect of 3,3ʹ-Diindolylmethane in Different Solvents on Pseudomonas Aeruginosa Biofilm
by: Malanchuk, S., et al.
Published: (2025)
by: Malanchuk, S., et al.
Published: (2025)
Detection of prostate specific ETS fusion transcripts in cancer samples
by: Mevs, L.V., et al.
Published: (2017)
by: Mevs, L.V., et al.
Published: (2017)
Amplification and co-regulators of androgen receptor gene in prostate cancer
by: Golias, Ch., et al.
Published: (2009)
by: Golias, Ch., et al.
Published: (2009)
Non-standard case of cancer of prostate gland (clinical case)
by: O. M. Zacheslavskyi, et al.
Published: (2018)
by: O. M. Zacheslavskyi, et al.
Published: (2018)
Probiotics in Pain Regulation: Mechanisms and Evidence from Preclinical and Clinical Studies
by: Starovoitova, S.O., et al.
Published: (2025)
by: Starovoitova, S.O., et al.
Published: (2025)
Profiling of metabolic biomarkers in the serum of prostate cancer patients
by: F. Ali, et al.
Published: (2020)
by: F. Ali, et al.
Published: (2020)
Implication of protocadherin-PC in the progression of the advanced prostate cancer
by: Giannakopoulos, X., et al.
Published: (2007)
by: Giannakopoulos, X., et al.
Published: (2007)
Modern algorithm of treatment of patients with prostate cancer with bone metastases
by: O. V. Ponomareva, et al.
Published: (2017)
by: O. V. Ponomareva, et al.
Published: (2017)
Expression pattern of genes associated with tumor microenvironment in prostate cancer
by: Gerashchenko, G.V., et al.
Published: (2018)
by: Gerashchenko, G.V., et al.
Published: (2018)
Hierarchical Modeling as the Basis of Technology of Preclinical Testing Blood Glucose Level Control Algorithms
by: S. I. Kiforenko
Published: (2017)
by: S. I. Kiforenko
Published: (2017)
Biochemical and cytogenetic indices of peripheral blood lymphocytes in patients with prostate cancer
by: E. A. Domina, et al.
Published: (2018)
by: E. A. Domina, et al.
Published: (2018)
Impact of metabolic syndrome on development of castration-resistant prostate cancer
by: Ju. A. Vinnik, et al.
Published: (2017)
by: Ju. A. Vinnik, et al.
Published: (2017)
Blood and urine polyamine as new diagnostic markers of prostate cancer
by: S. P. Zalietok, et al.
Published: (2019)
by: S. P. Zalietok, et al.
Published: (2019)
Assessment of gold nanoparticle effect on prostate cancer LNCaP cells
by: A. G. Reznikov, et al.
Published: (2015)
by: A. G. Reznikov, et al.
Published: (2015)
Assessment of gold nanoparticle effect on prostate cancer LNCaP cells
by: Reznikov, A.G., et al.
Published: (2015)
by: Reznikov, A.G., et al.
Published: (2015)
Expression of cancer-associated genes in prostate tumors at mRNA and protein levels
by: Gerashchenko, G.V., et al.
Published: (2019)
by: Gerashchenko, G.V., et al.
Published: (2019)
Mutation 6174delT in the BRCA2 gene in men with prostate cancer in Ukraine
by: Ye. V. Horodetska, et al.
Published: (2018)
by: Ye. V. Horodetska, et al.
Published: (2018)
Expression profile of miR¬200 family members and their targets in prostate cancer
by: M. Khorasani, et al.
Published: (2021)
by: M. Khorasani, et al.
Published: (2021)
Immunoglobulins of colostrum as novel molecular markers of preclinical diagnostics of autoimmune disorders in parturient women
by: Yu. Ya. Kit, et al.
Published: (2008)
by: Yu. Ya. Kit, et al.
Published: (2008)
Search for genes – potential markers of aggressiveness and metastasis for human prostate cancer
by: E. E. Rozenberh, et al.
Published: (2013)
by: E. E. Rozenberh, et al.
Published: (2013)
Effect of androgen suppression on bone mineral density in patients with prostate cancer
by: O. A. Chernichenko, et al.
Published: (2014)
by: O. A. Chernichenko, et al.
Published: (2014)
Effect of androgen suppression on bone mineral density in patients with prostate cancer
by: Chernichenko, O.A., et al.
Published: (2014)
by: Chernichenko, O.A., et al.
Published: (2014)
Apoptosis of peripheral blood lymphocytes of prostate cancer patients induced by in vitro irradiation
by: A. A. Filchenkov, et al.
Published: (2019)
by: A. A. Filchenkov, et al.
Published: (2019)
Correlation between histological type and immunohistochemical profile of prostate cancer and Gleason scale gradation
by: Iemelynova, A.A., et al.
Published: (2009)
by: Iemelynova, A.A., et al.
Published: (2009)
Similar Items
-
Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer
by: Kiselev, V.I., et al.
Published: (2014) -
Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts
by: Reznikov, A.G., et al.
Published: (2011) -
The function of poliamine metabolism in prostate cancer
by: Palavan-Unsal, N., et al.
Published: (2006) -
Expression of cancer-associated genes in prostate tumors
by: Rosenberg, E.E., et al.
Published: (2017) -
Gene expression of polyamine metabolism proteins in human prostate cancer and benign prostatic hyperplasia
by: V. V. Bentrad, et al.
Published: (2020)